Search results
Results from the WOW.Com Content Network
The impact of early cancer detection and the treatment outcomes vary, as there are instances where even with available treatment, early detection may not enhance the overall survival. If the cancer screening does not change the treatment outcome, the screening only prolongs the time the individual lived with the knowledge of their cancer diagnosis.
Cancer Cell is internationally regarded as one of the top cancer research and oncology journals. According to the Journal Citation Reports, the 2022 impact factor of the journal is 50.3. It is part of the Cell Press portfolio, which is owned by Elsevier. Issues are published monthly in print and online versions.
The Early Detection Research Network (EDRN) is a collaboration led by the National Cancer Institute (NCI) focused on the discovery of cancer biomarkers. The effort, started in 2000, includes both principal investigators and associate members from leading research institutions across the United States.
Cancer Cell International is an open-access, online-only journal which publishes articles focused on cancer cell. [2] Journal publishes also articles on cancer studies with the data from experiments. Publish research articles based on data in many fields, from cell proliferation to apoptosis, etc. [3]
Cancer Epidemiology (formerly known as Cancer Detection & Prevention) is a peer reviewed journal devoted to epidemiological cancer research. According to the Journal Citation Reports , the journal has a 2020 impact factor of 2.984.
Sidney Farber is regarded as the father of modern chemotherapy.. Cancer research has been ongoing for centuries. Early research focused on the causes of cancer. [1] Percivall Pott identified the first environmental trigger (chimney soot) for cancer in 1775 and cigarette smoking was identified as a cause of lung cancer in 1950.
Rates of 17 cancers have been rising among each generation since the baby boomers, with more young people being diagnosed below age 50 than in the past, new research suggests.
In cancer research and medicine, biomarkers are used in three primary ways: [19] To help diagnose conditions, as in the case of identifying early stage cancers (diagnostic) To forecast how aggressive a condition is, as in the case of determining a patient's ability to fare in the absence of treatment (prognostic)